ZIM Laboratories Limited (ZIMLAB.BO)
INR 113.15
(0.85%)
INR 113.15
(0.85%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 1.08 Billion INR | 75.52% |
| 2022 | 620 Million INR | 16.29% |
| 2021 | 533.13 Million INR | -35.24% |
| 2020 | 823.19 Million INR | -10.47% |
| 2019 | 919.46 Million INR | 19.1% |
| 2018 | 772.04 Million INR | -4.86% |
| 2017 | 811.46 Million INR | 0.73% |
| 2016 | 805.59 Million INR | -16.06% |
| 2015 | 959.69 Million INR | 3.19% |
| 2014 | 930 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 FY | 1.08 Billion INR | 75.52% |
| 2023 Q4 | 1.08 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 Q2 | 617.39 Million INR | 0.0% |
| 2022 Q4 | 620 Million INR | 0.0% |
| 2022 FY | 620 Million INR | 16.29% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q2 | 658.52 Million INR | 0.0% |
| 2021 Q2 | 876.38 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 533.13 Million INR | 0.0% |
| 2021 FY | 533.13 Million INR | -35.24% |
| 2021 Q1 | - INR | -100.0% |
| 2020 Q4 | 823.19 Million INR | 0.0% |
| 2020 Q2 | 651.08 Million INR | 0.0% |
| 2020 FY | 823.19 Million INR | -10.47% |
| 2019 Q4 | 919.46 Million INR | 0.0% |
| 2019 Q2 | 776.41 Million INR | 0.0% |
| 2019 FY | 919.46 Million INR | 19.1% |
| 2018 FY | 772.04 Million INR | -4.86% |
| 2018 Q4 | 772.04 Million INR | 0.0% |
| 2018 Q2 | 733.02 Million INR | 0.0% |
| 2017 Q4 | 811.46 Million INR | 0.0% |
| 2017 FY | 811.46 Million INR | 0.73% |
| 2016 FY | 805.59 Million INR | -16.06% |
| 2015 FY | 959.69 Million INR | 3.19% |
| 2014 FY | 930 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -208.459% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -6196.615% |
| Sigachi Industries Limited | 1.43 Billion INR | 23.927% |
| Bal Pharma Limited | 1.39 Billion INR | 22.073% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -554.717% |
| Medico Remedies Limited | 80.5 Million INR | -1251.789% |
| Lasa Supergenerics Limited | 220.76 Million INR | -392.949% |
| Venus Remedies Limited | 413.3 Million INR | -163.306% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -77.963% |
| Alpa Laboratories Limited | 52.46 Million INR | -1974.229% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 82.877% |
| Shilpa Medicare Limited | 9.37 Billion INR | 88.391% |
| Aarti Drugs Limited | 5.64 Billion INR | 80.714% |
| Lupin Limited | 29.21 Billion INR | 96.275% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 98.363% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 86.468% |
| Windlas Biotech Limited | 36.41 Million INR | -2888.86% |
| Suven Life Sciences Limited | 7.09 Million INR | -15233.859% |
| Eris Lifesciences Limited | 27.81 Billion INR | 96.087% |
| Valiant Laboratories Limited | 767.08 Million INR | -41.868% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 71.185% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 89.241% |
| Ipca Laboratories Limited | 14.38 Billion INR | 92.434% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -8.999% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 96.676% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 67.303% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | 47.472% |
| Laurus Labs Limited | 25.77 Billion INR | 95.778% |
| Piramal Pharma Limited | 47.1 Billion INR | 97.69% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -50.13% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 97.294% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 78.793% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 91.159% |
| Unichem Laboratories Limited | 2.47 Billion INR | 56.033% |
| Sequent Scientific Limited | 4.87 Billion INR | 77.686% |
| Novartis India Limited | 69.7 Million INR | -1461.326% |
| Wanbury Limited | 1.16 Billion INR | 6.576% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -67.431% |
| Wockhardt Limited | 23.56 Billion INR | 95.381% |
| Themis Medicare Limited | 957.92 Million INR | -13.605% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -1117.139% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 97.03% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -534.619% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 94.564% |
| Divi's Laboratories Limited | 30 Million INR | -3527.48% |
| NATCO Pharma Limited | 3.71 Billion INR | 70.683% |
| Gufic Biosciences Limited | 3.32 Billion INR | 67.312% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -232.187% |
| Ind-Swift Limited | 10.13 Billion INR | 89.268% |
| Procter & Gamble Health Limited | 95.6 Million INR | -1038.331% |
| FDC Limited | 205.18 Million INR | -430.372% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 43.74% |
| Granules India Limited | 13.15 Billion INR | 91.725% |
| Medicamen Biotech Limited | 308.17 Million INR | -253.129% |
| Alkem Laboratories Limited | 14.18 Billion INR | 92.328% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -2266.674% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -24694.805% |
| Brooks Laboratories Limited | 56.41 Million INR | -1828.861% |
| Megasoft Limited | 1.47 Billion INR | 25.993% |
| Strides Pharma Science Limited | 25.16 Billion INR | 95.676% |
| Neuland Laboratories Limited | 953.89 Million INR | -14.084% |
| Morepen Laboratories Limited | 289.99 Million INR | -275.267% |
| Hikal Limited | 8.17 Billion INR | 86.689% |
| Indoco Remedies Limited | 6.71 Billion INR | 83.805% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 61.849% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -243.875% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -10.49% |
| Hester Biosciences Limited | 2.44 Billion INR | 55.469% |